Clinical Effects of Guardcel® Nasal Packing on Endonasal Dacryocystorhinostomy
10.3341/jkos.2020.61.7.718
- Author:
Bo Hyun PARK
1
;
Jung Yul PARK
;
Hee Young CHOI
Author Information
1. Department of Ophthalmology, Pusan National University School of Medicine, Yangsan, Korea
- Publication Type:Original Article
- From:Journal of the Korean Ophthalmological Society
2020;61(7):718-725
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Purpose:To compare the clinical effects of Guardcel® (Genewel. Co, Seongnam, Korea) and Nasopore®(Polyganics, Rozenburglaan, Groningen, The Netherlands), two types of absorbable nasal packing materials after endonasal dacryocystorhinostomy.
Methods:A total of 41 patients (49 eyes) who underwent endonasal dacryocystorhinostomy from March 2017 to January 2019 were studied retrospectively. Twenty seven eyes were packed with Guardcel® and twenty two eyes with Nasopore®. We compared the postoperative anatomical and functional surgical success rates between the groups at 1 week, 1 month, 2 months, and 6 months , as well as the frequency of postoperative complications including bleeding.
Results:There was no significant difference between the Guardcel® and Nasopore® groups in the postoperative anatomical and functional surgical success rate at 1 week, 1 month, 2 months, or 6 months. Also, there was no significant group difference in the incidence of postoperative complications.
Conclusions:The anatomical and functional surgical success rates and incidence of postoperative complications, including bleeding, synechiae, infection, granuloma, and revision were similar between the Guardcel® and Nasopore® groups. Therefore, Guardcel® can be used safely and effectively as an absorbable nasal packing material in endonasal dacryocystorhinostomy treatment.